Perry Drug Recalls Leuprolide Micro Lupron Kits Due to Sterility Concerns
Perry Drug Inc. is recalling Leuprolide 50 mcg/0.1 mL Micro Lupron Kits in Kansas and Missouri due to potential sterility assurance risks identified during an FDA inspection.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of sterility assurance in a sterile compounded drug, which poses a significant risk of serious health consequences such as infection.
Plain-English summary
Perry Drug Inc. is recalling Leuprolide 50 mcg/0.1 mL Micro Lupron Kits, 5Ml, Compounded Rx, manufactured by Perry Drug Compounding Pharmacy in Overland Park, KS. The recall affects all lots of sterile products compounded by the pharmacy that are within their expiration date. The product was distributed in Kansas and Missouri.
The recall was initiated due to concerns associated with quality control procedures that present a potential risk to sterility assurance. These concerns were observed during a recent FDA inspection. The agency has classified this recall as Class II.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication. The specific lot codes associated with the recall include 141007DD, 141015GG, 141031II, 141031AA, and 141031JJ.
The recalled product
- Product
- Leuprolide 50 mcg/0.1 mL Micro Lupron Kit, 5Ml, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-1124-57
- Manufacturer
- Perry Drug Inc.
- Category
- Drug — Compounded Sterile Drug
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- 141007DD
- 11/7/14
- 141015GG
- 11/15/14
- 141031II
- 12/1/2014
- 141031AA
- 11/31/14
- 141031JJ
- 12/1/14
Distribution
Part of a larger recall action
This product is one of 17 recalled by Perry Drug Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 17 products in this recall →Related recalls
Same manufacturer · Perry Drug Inc.
See all →- SeverePerry Drug Recalls Cyclosporine Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Tri-mix Antidote Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls HCG Vials Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Methyl B12 Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
- SeverePerry Drug Recalls Phenylephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-03
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow access trays and PSI kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24